| Product Code: ETC9940439 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy RD in the UK |
4.2.2 Rising prevalence of genetic disorders driving demand for cell and gene therapy manufacturing services |
4.2.3 Favorable government regulations supporting the growth of the cell and gene therapy market in the UK |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing services |
4.3.2 Complex regulatory approval processes for cell and gene therapies in the UK |
5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Trends |
6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Number of clinical trials utilizing cell and gene therapies in the UK |
8.2 Investment in cell and gene therapy manufacturing infrastructure in the UK |
8.3 Number of partnerships and collaborations between UK-based companies and international firms in the cell and gene therapy sector |
9 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here